SYLVANT (Janssen Biotech, Inc.)
Welcome to the PulseAid listing for the SYLVANT drug offered from Janssen Biotech, Inc.. This Interleukin-6 Antagonist [EPC],Interleukin-6 Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Janssen Biotech, Inc. |
| NON-PROPRIETARY NAME: | siltuximab |
| SUBSTANCE NAME: | SILTUXIMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Interleukin-6 Antagonist [EPC],Interleukin-6 Antagonists [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2014-04-23 |
| END MARKETING DATE: | 0000-00-00 |
SYLVANT HUMAN PRESCRIPTION DRUG Details:
| Item Description | SYLVANT from Janssen Biotech, Inc. |
| LABELER NAME: | Janssen Biotech, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2014-04-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 57894-420_62edb225-0ee5-4872-bb8a-927341b7696b |
| PRODUCT NDC: | 57894-420 |
| APPLICATION NUMBER: | BLA125496 |
Other SILTUXIMAB Pharmaceutical Manufacturers / Labelers:
